Crizotinib-induced immunogenic cell death in non-small cell lung cancer (vol 10, 1486, 2019)

被引：4

作者：

Liu, Peng ^{[1
,2
,3
,4
,5
,6
]}

Zhao, Liwei ^{[1
,2
,3
,4
,5
,6
]}

Pol, Jonathan ^{[2
,3
,4
,5
,6
]}

Levesque, Sarah ^{[1
,2
,3
,4
,5
,6
]}

Petrazzuolo, Adriana ^{[1
,2
,3
,4
,5
,6
]}

Pfirschke, Christina ^{[7
]}

Engblom, Camilla ^{[7
,8
,9
]}

Rickelt, Steffen ^{[10
]}

Yamazaki, Takahiro ^{[11
]}

Iribarren, Kristina ^{[2
,3
,4
,5
,6
]}

Senovilla, Laura ^{[2
,3
,4
,5
,6
]}

Bezu, Lucillia ^{[1
,2
,3
,4
,5
,6
,12
]}

Vacchelli, Erika ^{[2
,3
,4
,5
,6
]}

Sica, Valentina ^{[2
,3
,4
,5
,6
]}

Melis, Andrea ^{[13
,14
]}

Martin, Tiffany ^{[13
,14
]}

Xia, Lin ^{[15
,16
,17
]}

Yang, Heng ^{[15
,16
,17
]}

Li, Qingqing ^{[15
,16
,17
]}

Chen, Jinfeng ^{[15
,16
,17
]}

Durand, Sylvere ^{[2
,3
,4
,5
,6
]}

Aprahamian, Fanny ^{[2
,3
,4
,5
,6
]}

Lefevre, Deborah ^{[2
,3
,4
,5
,6
]}

Broutin, Sophie ^{[18
]}

Paci, Angelo ^{[18
,19
]}

Bongers, Amaury ^{[18
]}

Minard-Colin, Veronique ^{[20
]}

Tartour, Eric ^{[21
,22
]}

Zitvogel, Laurence ^{[1
,17
,20
,23
,24
]}

Apetoh, Lionel ^{[13
,14
]}

Ma, Yuting ^{[15
,16
,17
]}

Pittet, Mikael J. ^{[7
,25
]}

Kepp, Oliver ^{[1
,2
,3
,4
,5
,6
]}

Kroemer, Guido ^{[2
,3
,4
,5
,6
,17
,26
,27
]}

机构：

[1] Univ Paris Sud, Fac Med, F-94270 Le Kremlin Bicetre, France

[2] Gustave Roussy Canc Campus, Cell Biol & Metabol Platforms, F-94805 Villejuif, France

[3] Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, F-75006 Paris, France

[4] Equipe Labellisee Ligue Natl Canc, Inst Natl Sante & Rech Med, UMR1138, F-75006 Paris, France

[5] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France

[6] Univ Paris 06, F-75006 Paris, France

[7] Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02139 USA

[8] Harvard Med Sch, Boston, MA 02139 USA

[9] Harvard Med Sch, Grad Program Immunol, Boston, MA 02238 USA

[10] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA

[11] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 14853 USA

[12] Hop Europeen Georges Pompidou, Dept Anaesthesiol, F-75015 Paris, France

[13] Ctr Rech INSERM LNC, UMR1231, Dijon, France

[14] Ctr Georges Francois Leclerc, Dept Med Oncol, F-21000 Dijon, France

[15] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100730, Peoples R China

[16] Peking Union Med Coll, Beijing 100730, Peoples R China

[17] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China

[18] Inst Gustave Roussy, Dept Pharmacol, F-94805 Villejuif, France

[19] Univ Paris Sud, Sch Pharm, F-92296 Chatenay Malabry, France

[20] GRCC, Inst Cancerol, F-94805 Villejuif, France

[21] Univ Paris 05, Sorbonne Paris Cite, INSERM U970, F-75006 Paris, France

[22] Hop Europeen Georges Pompidou, Dept Immunol, F-75015 Paris, France

[23] INSERM U1015, F-94805 Villejuif, France

[24] Ctr Clin Invest CIC1428, F-94805 Villejuif, France

[25] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA

[26] Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France

[27] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-14186 Stockholm, Sweden

来源：

NATURE COMMUNICATIONS | 2019年 / 10卷 / 1期

关键词：

D O I：

10.1038/s41467-019-09838-y

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The original version of this Article contained an error in the spelling of the author Lin Xia, which was incorrectly given as Xia Lin. This has now been corrected in both the PDF and HTML versions of the Article.

引用

页数：1

共 50 条

[1] Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Peng Liu
Liwei Zhao
Jonathan Pol
Sarah Levesque
Adriana Petrazzuolo
Christina Pfirschke
Camilla Engblom
Steffen Rickelt
Takahiro Yamazaki
Kristina Iribarren
Laura Senovilla
Lucillia Bezu
Erika Vacchelli
Valentina Sica
Andréa Melis
Tiffany Martin
Lin Xia
Heng Yang
Qingqing Li
Jinfeng Chen
Sylvère Durand
Fanny Aprahamian
Deborah Lefevre
Sophie Broutin
Angelo Paci
Amaury Bongers
Veronique Minard-Colin
Eric Tartour
Laurence Zitvogel
Lionel Apetoh
Yuting Ma
Mikael J. Pittet
Oliver Kepp
Guido Kroemer
[J]. Nature Communications, 10
[2] Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Liu, Peng
Zhao, Liwei
Pol, Jonathan
Levesque, Sarah
Petrazzuolo, Adriana
Pfirschke, Christina
Engblom, Camilla
Rickelt, Steffen
Yamazaki, Takahiro
Iribarren, Kristina
Senovilla, Laura
Bezu, Lucillia
Vacchelli, Erika
Sica, Valentina
Melis, Andrea
Martin, Tiffany
Lin, Xia
Yang, Heng
Li, Qingqing
Chen, Jinfeng
Durand, Sylvere
Aprahamian, Fanny
Lefevre, Deborah
Broutin, Sophie
Paci, Angelo
Bongers, Amaury
Minard-Colin, Veronique
Tartour, Eric
Zitvogel, Laurence
Apetoh, Lionel
Ma, Yuting
Pittet, Mikael J.
Kepp, Oliver
Kroemer, Guido
[J]. NATURE COMMUNICATIONS, 2019, 10 (1)
[3] Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Peng Liu
Liwei Zhao
Jonathan Pol
Sarah Levesque
Adriana Petrazzuolo
Christina Pfirschke
Camilla Engblom
Steffen Rickelt
Takahiro Yamazaki
Kristina Iribarren
Laura Senovilla
Lucillia Bezu
Erika Vacchelli
Valentina Sica
Andréa Melis
Tiffany Martin
Lin Xia
Heng Yang
Qingqing Li
Jinfeng Chen
Sylvère Durand
Fanny Aprahamian
Deborah Lefevre
Sophie Broutin
Angelo Paci
Amaury Bongers
Veronique Minard-Colin
Eric Tartour
Laurence Zitvogel
Lionel Apetoh
Yuting Ma
Mikael J. Pittet
Oliver Kepp
Guido Kroemer
[J]. Nature Communications, 10
[4] Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients
Dasom Jung
Ji Min Han
Jeong Yee
Jae Youn Kim
Hye Sun Gwak
[J]. Medical Oncology, 2018, 35
[5] Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients
Jung, Dasom
Han, Ji Min
Yee, Jeong
Kim, Jae Youn
Gwak, Hye Sun
[J]. MEDICAL ONCOLOGY, 2018, 35 (12)
[6] Successful treatment of crizotinib-induced dysgeusia by switching to alectinib in ALK-positive non-small cell lung cancer
Koizumi, Tomonobu
Fukushima, Toshirou
Tatai, Toshiharu
Kobayashi, Takashi
Sekiguchi, Nodoka
Sakamoto, Akiyuki
Sasaki, Shigeru
[J]. LUNG CANCER, 2015, 88 (01) : 112 - 113
[7] Crizotinib (Xalkori) for Non-Small Cell Lung Cancer
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1383): : 11 - 12
[8] Successful Crizotinib Rechallenge after Crizotinib-Induced Organizing Pneumonia in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer
Asai, Nobuhiro
Yokoi, Toyoharu
Yamaguchi, Etsuro
Kubo, Akihito
[J]. CASE REPORTS IN ONCOLOGY, 2014, 7 (03): : 681 - 684
[9] Entrectinib for ROS1-rearranged non-small cell lung cancer after crizotinib-induced interstitial lung disease: A case report
Tanimura, Mai
Kataoka, Nobutaka
Kunimatsu, Yusuke
Tsutsumi, Rei
Sato, Izumi
Nakano, Takayuki
Tanimura, Keiko
Takeda, Takayuki
[J]. RESPIROLOGY CASE REPORTS, 2021, 9 (11):
[10] Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients
Xin, Shuang
Fang, Wenfeng
Li, Jianwen
Li, Delan
Wang, Changzheng
Huang, Quanfei
Huang, Min
Zhuang, Wei
Wang, Xueding
Chen, Likun
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (03) : 725 - 737

← 1 2 3 4 5 →